Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Cara Therapeutics (NASDAQ: CARA)

Last Updated: Feb-24-2017 00:00:00

Premium Research

Cara Therapeutics (NASDAQ: CARA) Profile

Prior Close$14.55
Market Cap$0.41 B
PE Ratio
Cara Therapeutics Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics Inc. is based in Shelton United States.
SymbolCompanyMarket cap
AMGNAmgen$128.15 B
CELGCelgene Corp$92.94 B
GILDGilead Sciences Inc$90.87 B
BIIBBiogen Inc Cmn$61.49 B
REGNRegeneron Pharmaceutical$38.29 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$29.3 B
ILMNIllumina Inc$23.56 B
INCYIncyte Corporation$23.1 B
VRTXVertex Pharmaceutic$21.29 B

CARA Earnings

1st Quarter Earnings$-0.42 (2016-11-03)
2nd Quarter Earnings$-0.48 (2016-08-04)
3rd Quarter Earnings$-0.39 (2016-05-05)
4th Quarter Earnings$-0.35 (2016-03-10)
PE Ratio0
EPS Growth2.49%
Recent Earnings$-0.42
Annual EPS$-1.64
Market Capitalization$0.41 B
Insider Shareholder %0.077%
Annual Revenue$0 B
Number of Shares Outstanding27,280 Shares
Institutional Shareholder %43.29%
Annual Net Income$0B
TTM Net Profit Margin$100.35
One Year Return215.76%
Three Year Return-2.72%
Five Year Return16.42%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$-0.42
Annual EPS$-1.64
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD2.49%
PE Ratio
Recent Earnings$-0.42
Dividends per Share$
Stock Split Ratio

CARA Key Stats

Last Price$15.03
Net Change$0.48 (3.3%)
Ask Price$0
Open Price$14.32
Previous Close Price$14.55
High Price$15.4
Low Price$14.21
Number of Trades4,036
Fifty Two Week High$17.2 (2017-02-01)
Fifty Two Week Low$4.26 (2016-02-26)
Average Daily Volume1,746,146
Share Outstanding27,280 Shares
Total Dividend Payout$0/yr
Dividend Yield0%